Engineers Gate Manager
ESPR icon

Engineers Gate Manager’s Esperion Therapeutics ESPR Stock Holding History

Engineers Gate Manager’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Sell
104,790
-59,983
-36% -$168K ﹤0.01% 1727
2026
Q1 		$451K Buy
+164,773
New +$522K 0.01% 1462
2025
Q4 		– Sell
-102,770
Closed -$272K – 2222
2025
Q3 		$272K Buy
+102,770
New +$199K ﹤0.01% 1783
2025
Q2 		– Sell
-19,131
Closed -$27.5K – 2260
2025
Q1 		$27.5K Sell
19,131
-34,242
-64% -$63.1K ﹤0.01% 2071
2024
Q4 		$117K Buy
53,373
+34,983
+190% +$81.6K ﹤0.01% 1978
2024
Q3 		$30.3K Buy
+18,390
New +$37.1K ﹤0.01% 2003
2024
Q1 		– Sell
-52,932
Closed -$158K – 2017
2023
Q4 		$158K Buy
52,932
+4,541
+9% +$5.89K ﹤0.01% 1695
2023
Q3 		$47.4K Sell
48,391
-24,399
-34% -$35.3K ﹤0.01% 1657
2023
Q2 		$101K Buy
+72,790
New +$102K ﹤0.01% 1568
2022
Q4 		– Sell
-14,596
Closed -$98K – 1778
2022
Q3 		$98K Buy
+14,596
New +$100K 0.01% 1452
2022
Q1 		– Sell
-12,603
Closed -$63K – 1975
2021
Q4 		$63K Sell
12,603
-48,324
-79% -$387K ﹤0.01% 1851
2021
Q3 		$734K Buy
60,927
+23,151
+61% +$337K 0.04% 664
2021
Q2 		$799K Buy
37,776
+4,864
+15% +$117K 0.05% 533
2021
Q1 		$923K Buy
32,912
+199
+0.6% +$5.87K 0.05% 620
2020
Q4 		$851K Buy
+32,713
New +$980K 0.04% 668
2020
Q3 		– Sell
-8,820
Closed -$453K – 1759
2020
Q2 		$453K Buy
+8,820
New +$369K 0.02% 997
2019
Q3 		– Sell
-8,399
Closed -$391K – 1438
2019
Q2 		$391K Buy
+8,399
New +$394K 0.02% 799

Other funds holding ESPR

Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Arbitrage
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Engineers Gate Manager's ESPR Position: Q2 2026 in Review

Engineers Gate Manager reduced its Esperion Therapeutics (ESPR) stake by 36% in Q2 2026, selling an estimated $168K and leaving 104,790 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #1727.

Engineers Gate Manager first reported a position in ESPR in Q2 2019 and has held it in 17 quarters since. The position peaked at $923K in Q1 2021. 192 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.

  • Engineers Gate Manager held 104,790 shares of Esperion Therapeutics worth $331K as of Q2 2026.
  • Engineers Gate Manager sold 59,983 Esperion Therapeutics shares in Q2 2026, an estimated $168K.
  • Esperion Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1727 holding.
  • Engineers Gate Manager first reported a position in Esperion Therapeutics in Q2 2019 and has held it in 17 quarters since.
  • Engineers Gate Manager's Esperion Therapeutics position peaked at $923K in Q1 2021.
  • 192 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.